UK research reveals poor performance of National Health Service:
This article was originally published in Clinica
A report by the UK Institute of Economic Affairs has criticised the country's National Health Service (NHS) as being one of the worst in the developed world with virtually the lowest cancer and heart disease survival rates in Europe. The problem, say the co-authors David Green and Laura Casper, is caused by the UK's low healthcare expenditure with the country spending only 6.9% of GDP on healthcare compared with Germany which spends 10.7% and France which spends 9.6%. This results in shortages in medical equipment, drugs and human resources throughout the NHS, says the report.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.